Clinical Trials & Research
Many of today's most effective standard treatments are based on the results of previous clinical studies, and many cancer patients are now living longer because of progress made through clinical trials. Clinical trials offer high quality cancer care and also allow patients the opportunity to advance scientific knowledge and help future patients.
Ongoing research is essential in the fight against cancer, and it is one of the major objectives of the Edwards Comprehensive Cancer Center.
Clinical trials currently available
| Code | Description |
|---|---|
| B1931008 | An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combination with Rituximab Compared to Defined Investigator's Choice Therapy in Subjects with Relapsed Oor Refractory CD22-Positive Aggressive Non-Hodgkin Lymphoma who are not Candidates for Intensive High-Dose Chemotherapy. |
- Page last updated: Jan 4, 2013
-
